Pfizer says booster in children 5-11 raises antibodies against omicron
Posted on AllSides April 14th, 2022
From The Left
![](https://dev.allsides.com/sites/default/files/styles/news_large_image/public/220413-child-pfizer-vaccine-2021-ac-956p-934116.jpg?itok=Pn_nVdew)
Jeff Kowalsky / AFP via Getty Images file
A booster dose of the Pfizer-BioNTech Covid-19 vaccine raised antibody levels in children ages 5 to 11, the company said Thursday.
The additional shot, given six months after the two-dose primary series, led to a sixfold increase in antibodies against the original strain of the coronavirus.
The clinical trial of the booster shot included 140 children ages 5 through 11. In a smaller sub-analysis of 30 kids in the trial, Pfizer said the additional dose led to a thirtysixfold increase in antibodies against the omicron variant of the virus.
Pfizer announced...